Why is Sanofi India falling/rising?

As of 29-Jul, Sanofi India Ltd's stock price is currently at 5,781.20, reflecting a decrease of 8.8 points or 0.15%. The stock has underperformed its sector today by 1.39% and has experienced a trend reversal, gaining after three consecutive days of decline. However, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, the stock has shown negative returns over various periods, including a 2.48% decline over the past week and a 12.14% drop over the past year. Despite these challenges, the company boasts a high management efficiency with a return on equity of 35.83% and a low debt-to-equity ratio, which are positive indicators for potential investors.
In the broader market context, Sanofi India's short-term performance has been weaker than the benchmark Sensex, which has only declined by 1.03% over the past week. This underperformance is further highlighted by the stock's year-to-date return of -5.22%, contrasting sharply with the Sensex's gain of 4.09% in the same period. The falling investor participation, as evidenced by a 12.72% drop in delivery volume, may also contribute to the stock's struggles. However, the presence of high institutional holdings at 28.67% suggests that more informed investors are backing the company, which could provide some stability amidst the current volatility.